Skip to main content

Liver Oncology

Separator

11 courses availables

Liver Oncologydottime30 min

Advanced HCC: treatment strategies for patients ineligible for IO or those with progression on IO

Advanced HCC
eaccme EACCME®
Liver Oncologydottime30 min

The expanding role of immunotherapy (IO) in HCC: combining locoregional and systemic treatments in intermediate HCC

eaccme EACCME®
Liver Oncologydottime60 min

Treatment options for HCC patients who are not eligible for or progressed on IO

Clinical considerations and when to switch
eaccme EACCME®
Liver Oncologydottime30 min

**TEST** (By Moisés)The use of immunotherapy in HCC

**TEST** (By Moisés) Module 2: in-depth subgroup analyses and challenges
eaccme EACCME®
Liver Oncologydottime30 min

(TEST) The use of immunotherapy in HCC

(TEST) Module 1: efficacy and safety
eaccme EACCME®
Liver Oncologydottime30 min

The use of immunotherapy in HCC

Module 2: in-depth subgroup analyses and challenges
eaccme EACCME®
Liver Oncologydottime30 min

The use of immunotherapy in HCC

Module 1: efficacy and safety
eaccme EACCME®
Liver Oncologydottime60 min

Appropriate selection of patients for 1st line monotherapy in advanced or unresectable HCC and treatment management in relation with AEs

eaccme EACCME®
Liver Oncologydottime60 min

Appropriate selection of patients for combination immunotherapy in HCC: the now and the next

eaccme EACCME®
Liver Oncologydottime60 min

Treatment sequencing in advanced hepatocellular carcinoma

eaccme EACCME®
Liver Oncologydottime60 min

Understanding the changing treatment landscape in hepatocellular carcinoma and optimising therapy for the individual patient

eaccme EACCME®